Product Program year 2025 Source: CMS Open Payments

Colossus

Device Neuro

Open in the dashboard

General payments

$39,715

24 payments

Research payments

$8,000

1 payment

Through program year 2025, $39,715 in general payments and $8,000 in research payments were reported against Colossus (Neuro).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $35,390 7
2024 General $4,325 17
2024 Research $8,000 1

Breakdown

Who paid General payments · program years 2024–2025
  1. Scientia Vascular $39,715 24 payments
Top recipients General payments · program year 2024
  1. Rahul Shah Neurocritical Care · Shreveport, LA $617 14% · 1 payment
  2. Felix Song Neuroradiology · Honolulu, HI $601 14% · 1 payment
  3. Omar Choudhri Neurological Surgery · Philadelphia, PA $446 10% · 1 payment
  4. Trushar Patel Vascular & Interventional Radiology · Newport Beach, CA $365 8% · 1 payment
  5. Tust Techasith Diagnostic Radiology · Stanford, CA $365 8% · 1 payment

The top 5 of 17 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Neurological Surgery $1,407 33% · 6 practitioners
  2. Neuroradiology Radiology $695 16% · 2 practitioners
  3. Neurology Psychiatry & Neurology $645 15% · 4 practitioners
  4. Neurocritical Care Psychiatry & Neurology $617 14% · 1 practitioner
  5. Diagnostic Radiology Radiology $510 12% · 2 practitioners

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. California $1,281 30% · 6 recipients
  2. Louisiana $617 14% · 1 recipient
  3. Hawaii $601 14% · 1 recipient
  4. Pennsylvania $446 10% · 1 recipient
  5. Tennessee $416 10% · 2 recipients

The top 5 of 11 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

24 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record